Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence

NCT ID: NCT04291820

Last Updated: 2023-07-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative emergence delirium (ED) is a severe postoperative complication in paediatric anaesthesia. ED is defined as a state with psychomotor disturbance, perception disorder and state of excitation and anxiety. The incidence of ED in paediatric patients can be up to 80%. ED is associated with the increased morbidity of paediatric patients in the postoperative period. One of the potential triggers of ED is sevoflurane. Currently, there are only limited data about comparing the influence of anesthesiologic management on the ED incidence. The possible ED reduction could lead to reduced stay in a post-anaesthesia care unit (PACU), postoperative nausea and vomiting (PONV) incidence and the overall reduction of the postoperative adverse events incidence together with the higher satisfaction and the patients and the legal guardians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective randomized interventional single-blind study aims to compare the influence of the anaesthesiology management no the incidence of ED in the postoperative period in paediatric patients. Elective paediatric patients (2-10 years) scheduled for the planned adenoidectomy or adenoidectomy + micro-otoscopy/adenoidectomy + frenulum linguae discission will be included in the trial after signed informed consent form the legal guardian. In all patients, the 2 Eutectic Mixture of Local Anesthetics (EMLA) patch will be applied on the predefined skin area ( visible vein for venepuncture) between 45 minutes to 60 minutes before anaesthesia. The patients will be randomized at the operating theatre (allocation 1:1) into the experimental group (intravenous induction with propofol + opioid and anaesthesia maintenance according to this set bispectral index value with desflurane) and the control group (inhalation induction with sevoflurane mixed with air and oxygen and anaesthesia maintenance with sevoflurane). The primary aim of the study will be the incidence of ED defined by The Pediatric Anesthesia Emergence Delirium (PAED) scale, which will be measured at the , at the admission to PACU and in the 5th, 10th, 15th, 30th minute and at the moment of dismission from PACU. The secondary aim will be the time to oral intake (from the end of the surgery), the incidence of adverse events (PONV, bradycardia, hypotension), the need for concomitant medication (analgesic medication, sedative medication, antiemetic medication).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Emergence Delirium

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A prospective interventional single-blind randomized trial
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors
The participants will be blinded by the arm inclusion. The outcomes will be measured by the blinded nurse in the PACU

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intravenous induction with desflurane maintenance

The EMLA patch will be removed, and intravenous induction with propofol + opioid will be performed. The anaesthesia will be maintained with desflurane according to the levels of Bispectral index (BIS). Neuromuscular blockade is optional based on operator decision.

Group Type EXPERIMENTAL

Intravenous induction and desflurane anaesthesia maintenance

Intervention Type PROCEDURE

Anaesthesia will be inducted with intravenous propofol + opioid and maintained with desflurane according to the BIS levels

Inhalation induction with sevoflurane,sevoflurane maintenance

The EMLA patch will be removed, and inhalation induction with the sevoflurane will be performed. After peripheral vein cannulation, the opioid will be administered. The neuromuscular blockade is optional based on operator decision. Anaesthesia will be maintained with sevoflurane according to the set BIS levels.

Group Type ACTIVE_COMPARATOR

Inhalation induction with sevoflurane and anaesthesia maintenance with sevoflurane

Intervention Type PROCEDURE

Anaesthesia will be inducted with sevoflurane and maintained with sevoflurane according to the BIS levels

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intravenous induction and desflurane anaesthesia maintenance

Anaesthesia will be inducted with intravenous propofol + opioid and maintained with desflurane according to the BIS levels

Intervention Type PROCEDURE

Inhalation induction with sevoflurane and anaesthesia maintenance with sevoflurane

Anaesthesia will be inducted with sevoflurane and maintained with sevoflurane according to the BIS levels

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 2-10 years
* signed informed consent
* paediatric patient for elective adenoidectomy, or adenoidectomy with micro-otoscopy and/or frenulum discission

Exclusion Criteria

* allergy and hypersensitivity on local anaesthetics in EMLA patch, general anaesthetics, or soya beans or peanuts
* venepuncture refusal · neuromuscular disorder with the contraindication of inhalation anaesthetics
Minimum Eligible Age

2 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Brno University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Petr Štourač, MD

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brno University Hospital

Brno, South Moravian, Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Petr Stourac, assoc.Prof.MD.Ph.D

Role: CONTACT

5 3223 4261 ext. 00420

Jozef Klučka, MD

Role: CONTACT

532234696 ext. 00420

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KDAR SUP 2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Emergence Agitation of Sevoflurane in Pediatric
NCT06830564 COMPLETED PHASE2/PHASE3
Sevoflurane Induced Emergence Agitation
NCT02022488 COMPLETED PHASE4
Emergency Agitation in T&A
NCT01152476 COMPLETED NA